EWF
GSK icon

Epstein & White Financial’s GSK GSK Stock Holding History

Epstein & White Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,466
Closed -$234K – 83
2019
Q1 		$234K Sell
4,466
-1,328
-23% -$66.4K 0.13% 69
2018
Q4 		$280K Sell
5,794
-684
-11% -$33.7K 0.17% 55
2018
Q3 		$322K Sell
6,478
-4,111
-39% -$209K 0.21% 51
2018
Q2 		$534K Sell
10,589
-848
-7% -$42.7K 0.4% 39
2018
Q1 		$558K Sell
11,437
-220
-2% -$10.2K 0.36% 45
2017
Q4 		$552K Buy
+11,657
New +$539K 0.32% 51

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Epstein & White Financial's GSK Position: Q2 2019 in Review

Epstein & White Financial sold out of GSK (GSK) in Q2 2019, closing a stake of 4,466 shares — an estimated $234K sold.

Epstein & White Financial first reported a position in GSK in Q4 2017 and held it in 6 quarters. The position peaked at $558K in Q1 2018. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

  • Epstein & White Financial reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
  • Epstein & White Financial sold 4,466 GSK shares in Q2 2019, an estimated $234K.
  • Epstein & White Financial first reported a position in GSK in Q4 2017 and held it in 6 quarters.
  • Epstein & White Financial's GSK position peaked at $558K in Q1 2018.
  • 804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Epstein & White Financial's 13F filing for Q2 2019, filed 19 Jul 2019.